Live Quote · NASDAQZNTLHealthcare· Biotechnology

Zentalis Pharmaceuticals, Inc.

$1.36▲ 0.00%(+$0.00)
MKT CAP $133.64MNEXT EARNINGS Mar 3, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
60
Valuation
20
Profitability
50
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZNTL research report →

Analyst Price Target
$7.25+433.1% vs. today

Range $5 – $10

Analyst RatingBuy
9 Buy3 Hold0 Sell

Price Chart

+4.62% · this period
$6.61$3.96$1.30Nov 20May 26Nov 20
52-Week Range1% of range
Low
$1.30
Current
$1.36
High
$6.95